NCT03629717 2024-10-16
RANKL Inhibition and Breast Tissue Biomarkers
Washington University School of Medicine
Phase EARLY_PHASE1 Completed
Clinical Trials
3 trialsNCT03382574 2022-06-14
Pilot Study of Denosumab in BRCA1/2 Mutation Carriers Scheduled for Risk-Reducing Salpingo-Oophorectomy
National Cancer Institute (NCI)
Phase EARLY_PHASE1 Terminated
NCT02900469 2020-08-21
Presurgical Trial of Denosumab in Breast Cancer
NYU Langone Health
Phase EARLY_PHASE1 Completed